Accuray Inc.
1310 Chesapeake Terrace
Sunnyvale
California
94089
United States
Tel: 408-716-4600
Fax: 408-716-4601
Website: http://www.accuray.com/
Email: ics@accuray.com
492 articles about Accuray Inc.
-
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
2/27/2024
Accuray Incorporated announced its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024.
-
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
2/13/2024
Accuray Incorporated (NASDAQ: ARAY) announced today that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company's Radixact® radiation therapy delivery system.
-
Accuray Reports Fiscal 2024 Second Quarter Financial Results
1/31/2024
Accuray Incorporated reported financial results for the second quarter and six-months ended December 31, 2023.
-
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
1/25/2024
Accuray Incorporated announced that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer treatment capabilities with the purchase of the latest generation CyberKnife® S7™ System, the hospital's second CyberKnife radiation delivery device purchase.
-
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System
12/5/2023
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact ® System in Japan beginning November 30, 2023.
-
Accuray Reports Fiscal 2024 First Quarter Financial Results
11/7/2023
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023.
-
Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference
10/31/2023
Accuray Incorporated announced its participation in the 14th Annual Jefferies London Healthcare Conference.
-
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration
10/3/2023
Accuray Incorporated announced that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration.
-
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
10/2/2023
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for its Radixact ® System.
-
Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care
9/18/2023
Accuray Incorporated announced that the company has opened the doors of its new global training facility, the Accuray Center for Education, located at its corporate headquarters in Madison, Wisconsin.
-
Accuray to Host Investor Day at ASTRO on October 3, 2023
9/14/2023
Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3, 2023, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting.
-
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market
8/10/2023
Accuray Incorporated announced that the company has received 510 clearance from the U.S. Food and Drug Administration for its VitalHold™* breast package on the Radixact® System.
-
Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results
8/9/2023
Accuray Incorporated reported financial results for the fourth quarter and fiscal 2023, ended June 30, 2023.
-
Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023
7/26/2023
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 9, 2023.
-
Accuray Incorporated Announces Its Addition to the Russell 2000® Index
6/26/2023
Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will be included in the Russell 2000 ® Index and the broad-market Russell 3000 ® Index, which will be effective today.
-
Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business
6/21/2023
Cognizant announced that it is partnering with Accuray Incorporated to support the company's deployment of SAP S/4HANA to obtain better data and analytics, and achieve greater business efficiencies.
-
Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness
5/17/2023
Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife® and TomoTherapy® platforms, including the latest generation Radixact® System.
-
Accuray Reports Fiscal 2023 Third Quarter Financial Results
4/26/2023
Accuray Incorporated reported financial results for the third quarter of fiscal 2023 ended March 31, 2023.
-
Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023
4/13/2023
Accuray Incorporated will report financial results for the third quarter of fiscal year 2023, ended March 31, 2023, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on April 26, 2023.
-
Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference
3/8/2023
Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33rd Annual Oppenheimer Healthcare Conference taking place March 13-15, 2023.